Dr Reddy tumbles on reporting lower than expected Q1 numbers

20 Jul 2012 Evaluate

Dr Reddys Laboratories is currently trading at Rs. 1607.20, down by 48.40 points or 2.92% from its previous closing of Rs. 1655.60 on the BSE.

The scrip opened at Rs. 1651.00 and has touched a high and low of Rs. 1651.00 and Rs. 1598.00 respectively. So far 25787 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1818.00 on 20-Apr-2012 and a 52 week low of Rs. 1387.00 on 22-Aug-2011.

Last one week high and low of the scrip stood at Rs. 1725.00 and Rs. 1598.00 respectively. The current market cap of the company is Rs. 27254.17 crore.

The promoters holding in the company stood at 25.57% while Institutions and Non-Institutions held 40.32% and 17.32% respectively. 

Dr Reddy’s has reported results for first quarter ended June 30, 2012.

On the standalone basis, the company has posted a fall of 60.87% in its net profit at Rs 177.66 crore for the quarter ended June 30, 2012 as compared to Rs 454.05 crore for the same quarter in the previous year. However, total income has increased by 4.70% at Rs 1834.94 crore for quarter under review as compared to Rs 1752.50 crore for the quarter ended June 30, 2011.

On the consolidated basis, the company has posted a rises of 27.87% in its net profit at Rs 335.98 crore for the quarter ended June 30, 2012 as compared to Rs 262.74 crore for the same quarter in the previous year. Total income has increased by 28.31% at Rs 2562.46 crore for quarter under review as compared to Rs 1997.02 crore for the quarter ended June 30, 2011.

Dr Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs. 

Dr. Reddys Lab Share Price

1340.80 -1.65 (-0.12%)
23-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1814.50
Dr. Reddys Lab 1340.80
Cipla 1476.45
Lupin 2160.20
Zydus Lifesciences 972.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.